Pfizer said last week it would pay $47.50 per share for Metsera, and an extra $22.50 per share if its drugs hit certain ...

For its part, OrderlyMeds looks to continue shifting the paradigm in weight loss through its whole-person approach to health ...

A new oral weight loss medication, orforglipron, demonstrated meaningful weight loss results in phase 3 trials, potentially ...

Sister Wives star Christine Brown has been on a health and wellness journey — but since dropping 40 pounds, rumors have ...

New York City doctors reveals how weight-loss drugs reduce inflammatory cytokines by decreasing fat cells, potentially ...

Weight loss drugs have represented an enormous growth area for biotech and pharma companies over the past couple of years.

Fractyl Health said its experimental outpatient procedure helped preserve weight loss after stopping a GLP-1 drug in a study, ...

Ozempic has been approved in India for type 2 diabetes. The blockbuster drug by Danish drugmaker Novo Nordisk has taken the ...

Swiss drugmaker Roche signalled its ambition to join Eli Lilly and Novo Nordisk at the top of the booming weight-loss market ...

Pfizer has agreed to pay up to $7.3 billion for weight-loss drug developer Metsera in a deal that gets the New York drugmaker ...

Semaglutide (better known as Wegovy) may help people with obesity lose up to 25% of their body weight when used at a higher ...